Stock Price
16.32
Daily Change
-0.43%
Monthly
-17.16%
Yearly
240.71%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 116.51 -2.15 -1.81% 11.08%
Adma Biologics 1.45 -0.05 -3.33% -23.68%
Agenus 3.23 -0.11 -3.29% -12.94%
Alexion Pharmaceuticals 182.50 0 0% 70.54%
Amgen 201.09 -2.88 -1.41% -10.55%
AstraZeneca 8,411.00 -97.00 -1.14% 8.25%
Astrazeneca 56.58 0.24 0.43% 7.55%
Biogen 242.90 -7.23 -2.89% -0.36%
BioMarin Pharmaceutical 87.58 -1.99 -2.22% 8.93%
Bristol-Myers Squibb 56.53 -0.28 -0.49% -10.34%
Chimerix 5.90 -0.33 -5.30% 54.86%
Dynavax Technologies 16.32 -0.07 -0.43% 240.71%
Gilead Sciences 70.27 0.20 0.29% 17.06%
Glaxosmithkline 41.02 -0.58 -1.39% 10.66%
GW Pharmaceuticals 218.96 0 0% 108.53%
Idera Pharmaceuticals 0.69 -0.0001 -0.01% -83.92%
Merck & Co 79.16 -3.12 -3.79% -0.88%
Neurocrine Biosciences 86.98 -0.88 -1.00% -8.98%
Minerva Neurosciences 1.06 0 0% -73.57%
Nektar Therapeutics 11.21 -0.41 -3.53% -33.23%
Novartis 74.72 -1.85 -2.42% -7.82%
Pfizer 54.00 3.11 6.11% 45.04%
Regeneron Pharmaceuticals 643.35 -4.83 -0.75% 25.15%
Roche Holding 358.60 -3.45 -0.95% 18.55%
Sarepta Therapeutics 79.62 -1.36 -1.68% -42.78%
TG Therapeutics 23.98 -1.43 -5.63% -20.83%
Vertex Pharmaceuticals 183.59 -2.65 -1.42% -19.02%

Indexes Price Day Year
NASDAQ 15492 -353.57 -2.23% 26.92%
US2000 2246 -85.52 -3.67% 21.06%

Dynavax Technologies
Dynavax Technologies Corporation is a commercial-stage biopharmaceutical company that is focused on developing and commercializing novel vaccines. The Company's products include HEPLISAV-B and CpG 1018TM. The HEPLISAV-B is for the prevention of infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The Company also manufactures and sells CpG 1018TM, the adjuvant used in HEPLISAV-B. The Company also engaged in developing CpG 1018 as a premier vaccine adjuvant through research collaborations and partnerships.